Pediatrix Medical Group, Inc.
For the period ended Oct 29, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 29, 2026 · Filed Oct 29, 2026
Use the contents to explore the available documents and sections.
MD$31.29-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Net revenue | $501,374 | $492,875 | $1,465,353 | $1,420,078 |
| Operating expenses: | ||||
| Practice salaries and benefits | 341,543 | 332,326 | 1,023,403 | 992,859 |
| Practice supplies and other operating expenses | 19,559 | 20,200 | 56,244 | 59,500 |
| General and administrative expenses | 62,701 | 60,793 | 184,258 | 175,111 |
| Depreciation and amortization | 6,243 | 5,551 | 18,144 | 16,196 |
| Transformational and restructuring related expenses | 6,118 | 5,954 | 19,515 | 16,393 |
| Total operating expenses | 436,164 | 424,824 | 1,301,564 | 1,260,059 |
| Income from operations | 65,210 | 68,051 | 163,789 | 160,019 |
| Investment and other income | 5,864 | 5,883 | 15,172 | 14,347 |
| Net gain on investments in divested businesses | — | 20,906 | — | 20,906 |
| Interest expense | (8,127) | (8,941) | (24,564) | (27,225) |
| Equity in earnings of unconsolidated affiliate | 2,045 | 1,879 | 3,439 | 2,790 |
| Total non-operating (expenses) income | (218) | 19,727 | (5,953) | 10,818 |
| Income before income taxes | 64,992 | 87,778 | 157,836 | 170,837 |
| Income tax provision | (18,001) | (16,070) | (41,430) | (39,132) |
| Net income | $46,991 | $71,708 | $116,406 | $131,705 |
| Other comprehensive income, net of tax | ||||
| Unrealized holding (loss) gain on investments, net of tax of $423, $101, $720, and $496 | (1,354) | 309 | (2,350) | 1,517 |
| Total comprehensive income | $45,637 | $72,017 | $114,056 | $133,222 |
| Per common and common equivalent share data (diluted): | ||||
| Net income | $0.59 | $0.84 | $1.43 | $1.54 |
| Weighted average common shares | 79,729 | 85,613 | 81,260 | 85,559 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.